Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 84751-84800 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05300503
Evaluating the Use of a Remote Telehome Monitoring Hypertension Program for Patients Receiving Virtual Care
NA
Active, not recruiting
100 participants
Started: Aug 4, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05304585
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
PHASE3
Recruiting
205 participants
Started: Aug 4, 2022 · Completed: Jun 30, 2030
3 conditions
2 sponsors
177 locations
NCT05456724
A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Aug 4, 2022 · Completed: Jul 31, 2024
2 conditions
2 sponsors
1 location
NCT06809712
Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
PHASE1
Recruiting
29 participants
Started: Aug 4, 2022 · Completed: Oct 31, 2027
1 condition
1 sponsor
1 location
NCT05453721
Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane(IMPLANE-0529)
NA
Recruiting
272 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2027
2 conditions
10 sponsors
1 location
NCT05184933
Sleep and Circadian Mechanisms in Hypertension
NA
Recruiting
32 participants
Started: Aug 4, 2022 · Completed: Mar 30, 2028
5 conditions
1 sponsor
1 location
NCT05477524
An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)
PHASE3
Active, not recruiting
12,547 participants
Started: Aug 4, 2022 · Completed: Dec 26, 2025
1 condition
2 sponsors
120 locations
NCT05520359
Spinal Stimulation and Mobility Devices
NA
Recruiting
20 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2026
5 conditions
2 sponsors
1 location
NCT05491512
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
PHASE2
Recruiting
121 participants
Started: Aug 4, 2022 · Completed: Aug 4, 2026
5 conditions
1 sponsor
7 locations
NCT05424835
A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
PHASE3
Active, not recruiting
381 participants
Started: Aug 4, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05349214
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
PHASE3
Active, not recruiting
506 participants
Started: Aug 4, 2022 · Completed: May 12, 2027
1 condition
1 sponsor
146 locations
NCT05225428
Video Education With Result Dependent dIsclosure
NA
Recruiting
1,020 participants
Started: Aug 4, 2022 · Completed: Sep 1, 2026
9 conditions
3 sponsors
1 location
NCT05464030
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
PHASE1
Recruiting
200 participants
Started: Aug 4, 2022 · Completed: Aug 7, 2026
1 condition
2 sponsors
35 locations
NCT05670262
The Roles of Human Microbiome and Vitamin D in the Development of Childhood Allergic Diseases
N/A
Recruiting
6,000 participants
Started: Aug 4, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT05638490
Study on Prenatal Diagnosis and Closed-loop Management System of Congenital Talipes Equinovarus
N/A
Recruiting
100 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05489237
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
PHASE1
Recruiting
269 participants
Started: Aug 3, 2022 · Completed: Nov 3, 2027
5 conditions
1 sponsor
18 locations
NCT04676048
ASC618 Gene Therapy in Hemophilia A Patients
PHASE1/PHASE2
Recruiting
12 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06413004
Brachyspira and Intestinal Allergy-like Immune Reactions in Patients With Irritable Bowel Syndrome (IBS)
NA
Recruiting
200 participants
Started: Aug 3, 2022 · Completed: Jan 1, 2027
2 conditions
1 sponsor
1 location
NCT05468970
Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors
N/A
Recruiting
6,000 participants
Started: Aug 3, 2022 · Completed: Jul 31, 2032
2 conditions
1 sponsor
1 location
NCT04531995
One Million Cancer Treatment Months
N/A
Recruiting
166,000 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
4 locations
NCT05463263
A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
PHASE1/PHASE2
Recruiting
180 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
15 locations
NCT05261399
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
PHASE3
Recruiting
324 participants
Started: Aug 3, 2022 · Completed: Dec 17, 2026
2 conditions
1 sponsor
283 locations
NCT05488366
Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma
EARLY_PHASE1
Active, not recruiting
9 participants
Started: Aug 3, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06054321
Psychopharmacotherapy for Depressive Patients
NA
Recruiting
400 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT05411016
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus
PHASE1
Active, not recruiting
157 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
23 locations
NCT05351333
Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation
NA
Recruiting
66 participants
Started: Aug 3, 2022 · Completed: Jul 31, 2026
3 conditions
2 sponsors
1 location
NCT05217615
Parent Training for Parents of Toddlers Born Very Premature:
NA
Active, not recruiting
490 participants
Started: Aug 3, 2022 · Completed: Apr 1, 2026
4 conditions
4 sponsors
3 locations
NCT05455840
A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease
NA
Active, not recruiting
15 participants
Started: Aug 3, 2022 · Completed: Apr 11, 2024
3 conditions
1 sponsor
1 location
NCT04847453
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
PHASE1
Recruiting
24 participants
Started: Aug 3, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
16 locations
NCT05719259
Perpetual Observational Study - Ventilator Associated Pneumonia
N/A
Recruiting
20,000 participants
Started: Aug 3, 2022 · Completed: Mar 1, 2026
1 condition
4 sponsors
35 locations
NCT05180799
A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
PHASE1/PHASE2
Active, not recruiting
320 participants
Started: Aug 3, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
12 locations
NCT05023889
Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy
EARLY_PHASE1
Active, not recruiting
10 participants
Started: Aug 3, 2022 · Completed: Feb 25, 2026
5 conditions
2 sponsors
1 location
NCT05348876
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
PHASE4
Recruiting
50 participants
Started: Aug 3, 2022 · Completed: Jan 28, 2026
1 condition
1 sponsor
25 locations
NCT06523582
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
N/A
Recruiting
750 participants
Started: Aug 3, 2022 · Completed: Mar 1, 2037
26 conditions
3 sponsors
3 locations
NCT06732531
Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
PHASE1/PHASE2
Recruiting
48 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
6 locations
NCT05434026
Chinese Colorectal Cancer Database
N/A
Recruiting
200,000 participants
Started: Aug 3, 2022 · Completed: Jun 22, 2032
3 conditions
8 sponsors
1 location
NCT05306340
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
PHASE3
Active, not recruiting
373 participants
Started: Aug 3, 2022 · Completed: Oct 15, 2026
1 condition
1 sponsor
171 locations
NCT05178862
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
PHASE3
Recruiting
220 participants
Started: Aug 3, 2022 · Completed: Feb 28, 2027
2 conditions
1 sponsor
75 locations
NCT06498323
Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT
PHASE4
Recruiting
160 participants
Started: Aug 3, 2022 · Completed: Aug 31, 2025
3 conditions
1 sponsor
1 location
NCT05446272
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
NA
Recruiting
478 participants
Started: Aug 3, 2022 · Completed: Mar 31, 2027
3 conditions
2 sponsors
20 locations
NCT05493267
A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB
PHASE4
Recruiting
30 participants
Started: Aug 3, 2022 · Completed: Aug 3, 2027
2 conditions
4 sponsors
2 locations
NCT05507411
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
PHASE2
Recruiting
100 participants
Started: Aug 3, 2022 · Completed: Apr 30, 2027
1 condition
2 sponsors
3 locations
NCT05297448
Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis
PHASE3
Active, not recruiting
466 participants
Started: Aug 3, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
188 locations
NCT05305911
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
PHASE2
Recruiting
81 participants
Started: Aug 3, 2022 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT04956133
IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment
NA
Recruiting
250 participants
Started: Aug 3, 2022 · Completed: Jun 1, 2028
2 conditions
5 sponsors
2 locations
NCT05410145
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
PHASE1/PHASE2
Recruiting
442 participants
Started: Aug 3, 2022 · Completed: Feb 28, 2027
1 condition
1 sponsor
49 locations
NCT05554692
Peripheral and Central Influences on Auditory Temporal Processing & Speech Perception in Older Cochlear Implantees
NA
Enrolling by invitation
300 participants
Started: Aug 3, 2022 · Completed: Mar 31, 2027
4 conditions
3 sponsors
1 location
NCT05444088
Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma
PHASE1/PHASE2
Recruiting
129 participants
Started: Aug 2, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05454358
Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP
PHASE2/PHASE3
Recruiting
299 participants
Started: Aug 2, 2022 · Completed: Jul 9, 2030
1 condition
2 sponsors
1 location
NCT05198661
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
NA
Recruiting
3,500 participants
Started: Aug 2, 2022 · Completed: Aug 2, 2032
1 condition
1 sponsor
62 locations
Previous
1
More pages
1693
1694
1695
1696
1697
1698
1699
More pages
2369
Next